Traditional Chinese medicine for Covid-19

Traditional Chinese medicine for Covid-19

https://commons.wikimedia.org/wiki/File:%E8%87%BA%E7%81%A3%E6%B8%85%E5%86%A0%E4%B8%80%E8%99%9F(%E8%8E%8A%E6%9D%BE%E6%A6%AE%E3%80%81%E9%A0%86%E5%A4%A9%E5%A0%82%E3%80%81%E5%8B%B8%E5%A5%89%E5%A0%82%E5%92%8C%E7%AB%8B%E5%BA%B7).jpg

Research Literatures:

**************************

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

Biomed Pharmacother. 2021 Jan;133:111037. doi: 10.1016/j.biopha.2020.111037. Epub 2020 Nov 19.

https://pubmed.ncbi.nlm.nih.gov/33249281/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676327/pdf/main.pdf

The Traditional Chinese Medicine Formula Jing Guan Fang for Preventing SARS-CoV-2 Infection: From Clinical Observation to Basic Research

Front Pharmacol. 2022 Mar 21;13:744439. doi: 10.3389/fphar.2022.744439. eCollection 2022.

https://pubmed.ncbi.nlm.nih.gov/35387343/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978714/pdf/fphar-13-744439.pdf

The Using of Chinese Medicine Decoction, Jing-Guan-Fang, in Confirmed Cases and Their Exposed Family of COVID-19 Infection

https://www.airitilibrary.com/Publication/alDetailedMesh?docid=18186076-202112-202112010009-202112010009-13-24

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL pro and PL pro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)

Eur J Pharmacol. 2021 Jan 15;891:173759. doi: 10.1016/j.ejphar.2020.173759. Epub 2020 Nov 27.

https://pubmed.ncbi.nlm.nih.gov/33249077/

2022-05-13

Covid-19 Rapid Test 新冠 快篩試劑

Covid-19 Rapid Test 新冠 快篩試劑 

(Roche ) 實名制 購買的 快篩試劑 (Roche 羅氏)

如果放超過30分鐘以上，才出現第二條線，仍然判讀為陰性：

(Roche Licensed ) 7-11 賣的 快篩試劑 (Roche 羅氏 授權)

(Abbott ) 7-11 賣的 快篩試劑 (Abbott 亞培)

(Korean ) 某醫院使用的快篩，

韓國GenBody

某醫院使用的快篩

2022-05-14

2022-10-14

What to Know about the Omicron Subvariant BA.2 and Other COVID-19 Variants

What to Know about the Omicron Subvariant BA.2 and Other COVID-19 Variants

https://www.mskcc.org/coronavirus/what-we-know-covid19-variants?utm_campaign=013122-COVID-Omicron-BA.2&utm_source=Facebook&utm_medium=Organic&utm_content=Expertise&fbclid=IwAR3Ye8WbUpe1FvrGwjTRaLFDtNXEsLuwTcdk0ev8-lCvkeoyGHRsx95OPPI

https://commons.wikimedia.org/wiki/File:Novel_Coronavirus_SARS-CoV-2.jpg

2022-01-20

2022-02-01

Six-month sequelae of post-vaccination SARS-CoV-2 infection - PubMed

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections

Maxime Taquet et al. Brain Behav Immun. 2022.

https://pubmed.ncbi.nlm.nih.gov/35447302/

(recorded between January 1 and August 31, 2021, i.e. before the emergence of the Omicron variant).

Receiving at least one COVID-19 vaccine dose was associated with a significantly lower risk of respiratory failure, ICU admission, intubation/ventilation, hypoxaemia, oxygen requirement, hypercoagulopathy/venous thromboembolism, seizures, psychotic disorder, and hair loss (each as composite endpoints with death to account for competing risks; HR 0.70-0.83, Bonferroni-corrected p < 0.05)

Receiving 2 vaccine doses was associated with lower risks for most outcomes. 

2022-05-07

Vitamin D Low Level associated with COVID-19 positive for 1.77 times 維他命D 太低得新冠肺炎是 1.77倍

Vitamin D Status in Hospitalized Patients With SARS-CoV-2 Infection 

José L Hernández, Daniel Nan, Marta Fernandez-Ayala, Mayte García-Unzueta, Miguel A Hernández-Hernández, Marcos López-Hoyos, Pedro Muñoz Cacho, José M Olmos, Manuel Gutiérrez-Cuadra, Juan J Ruiz-Cubillán

The Journal of Clinical Endocrinology & Metabolism, dgaa733, https://doi.org/10.1210/clinem/dgaa733

Published: 27 October 2020

美國 JCEM 的醫學研究：

維他命D 的血中濃度，新冠肺炎住院病人 比一般人低，

新冠肺炎住院病人維他命D 的血中濃度是 13.8±7.2 ng/ml, 

一般人平均是 20.9±7.4 ng/ml, 有顯著差異 (p<0.0001)。

https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgaa733/5934827

***************************

Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results

David O. Meltzer, MD, PhD; Thomas J. Best, PhD; Hui Zhang, PhD; et al

JAMA Netw Open. 2020;3(9):e2019722. doi:10.1001/jamanetworkopen.2020.19722


Findings:  In this cohort study of 489 patients who had a vitamin D level measured in the year before COVID-19 testing, the relative risk of testing positive for COVID-19 was 1.77 times greater for patients with likely deficient vitamin D status compared with patients with likely sufficient vitamin D status, a difference that was statistically significant.


美國 JAMA 的醫學研究：

維他命D 太低得新冠肺炎 的機率 是 維他命D 正常人的 1.77倍

所以最好偶爾需要曬一下太陽，或是補充 維他命D 製劑。

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770157


2020-09-14
2020-11-06

COVID-19 SARS-CoV-2 Summary of Clinical Researches

COVID-19 SARS-CoV-2 Summary of Clinical Researches

COVID-19 新冠肺炎 SARS-CoV-2 新冠病毒的臨床研究摘要


High levels of suPAR linked to acute kidney injury in patients with COVID-19

Journal of the American Society of Nephrology. Sep 2020

COVID-19 新冠肺炎病人的急性腎損傷與血中 suPAR 高濃度有關

*********************

Elevated T-cell, neutrophil activation markers linked to severe clinical outcomes in COVID-19: Study

The Journal of Allergy and Clinical Immunology. 2020 Sep.

COVID-19 新冠肺炎重症病人與T細胞、中性球 sTIM-3 高濃度有關

2020-10-05

Corticosteroids Reduce Mortality Among Critically COVID-19 類固醇 降低 新冠病毒肺炎 死亡率

Corticosteroids Reduce Mortality Among Critically Ill COVID-19 

類固醇 降低 新冠病毒肺炎 的死亡率

引用醫學研究論文：

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

使用 類固醇 可降低 重症 COVID-19 新冠病毒肺炎 28天內死亡率

JAMA. doi:10.1001/jama.2020.17023

Published online September 2, 2020.

https://www.wsj.com/articles/covid-19-deaths-significantly-reduced-by-use-of-steroids-analysis-says-11599055201?reflink=line

*********

Study suggests inhaled corticosteroids do not protect patients with COPD, asthma against SARS-CoV-2 infection

使用吸入的類固醇，不能預防 SARS-CoV-2 感染

2020-09-02

2020-10-05